Enhancement of NK, but not K cell activity by different interferons. 1980

H Rumpold, and D Kraft, and O Scheiner, and P Meindl, and G Bodo

Two different interferons derived either from a human lymphoblastoid cell line (Namalva) or from human fibroblasts were tested for their ability to modulate natural killer (NK) or killer (K) cell activity. The lymphoblastoid interferon was purified by ion-exchange chromatography on SP-Sephadex C-25 and gel filtration on Sephadex G-100, the fibroblast-derived interferon was purified by chromatography on porous glass beads. Evidence is presented that NK cell activity is enhanced by both of these interferons being active to a similar extent. When tissue culture cells are employed as targets for measurement of K cell activity, the augmentation of cytotoxicity by interferons has to be attributed to the inherent NK cell activity. With the use of the autologous hapten-coated target cells and of affinity chromatography purified antibodies, the cytotoxicity is displayed solely by K cells and this activity is not enhanced by either interferons tested.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D010400 Penicillin G A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission. Benzylpenicillin,Benpen,Benzylpenicillin Potassium,Coliriocilina,Crystapen,Or-pen,Parcillin,Pekamin,Pengesod,Penibiot,Penicilina G Llorente,Penicillin G Jenapharm,Penicillin G Potassium,Penicillin G Sodium,Penicillin GrĂ¼nenthal,Penilevel,Peniroger,Pfizerpen,Sodiopen,Sodipen,Sodium Benzylpenicillin,Sodium Penicillin,Unicilina,Ursopen,Van-Pen-G
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human

Related Publications

H Rumpold, and D Kraft, and O Scheiner, and P Meindl, and G Bodo
January 1990, International journal of immunopharmacology,
H Rumpold, and D Kraft, and O Scheiner, and P Meindl, and G Bodo
January 1990, Comptes rendus des seances de la Societe de biologie et de ses filiales,
H Rumpold, and D Kraft, and O Scheiner, and P Meindl, and G Bodo
January 1992, Thymus,
H Rumpold, and D Kraft, and O Scheiner, and P Meindl, and G Bodo
July 2003, Medicine and science in sports and exercise,
H Rumpold, and D Kraft, and O Scheiner, and P Meindl, and G Bodo
March 1991, Journal of neuroimmunology,
H Rumpold, and D Kraft, and O Scheiner, and P Meindl, and G Bodo
January 1985, Progress in clinical and biological research,
H Rumpold, and D Kraft, and O Scheiner, and P Meindl, and G Bodo
February 2018, Immunologic research,
H Rumpold, and D Kraft, and O Scheiner, and P Meindl, and G Bodo
July 2011, Infection and immunity,
H Rumpold, and D Kraft, and O Scheiner, and P Meindl, and G Bodo
October 1980, Blood,
H Rumpold, and D Kraft, and O Scheiner, and P Meindl, and G Bodo
January 1988, Acta microbiologica Hungarica,
Copied contents to your clipboard!